424 related articles for article (PubMed ID: 21258054)
1. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy.
Bowman P; Osborne NJ; Sturley R; Vaidya B
QJM; 2012 Feb; 105(2):189-93. PubMed ID: 21258054
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic treatment of hyperthyroidism during pregnancy.
Cassina M; Donà M; Di Gianantonio E; Clementi M
Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):612-9. PubMed ID: 22511519
[TBL] [Abstract][Full Text] [Related]
3. Antenatal carbimazole and choanal atresia: a new embryopathy.
Wolf D; Foulds N; Daya H
Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):1009-11. PubMed ID: 16982979
[TBL] [Abstract][Full Text] [Related]
4. Antithyroid drugs.
Cooper DS
N Engl J Med; 2005 Mar; 352(9):905-17. PubMed ID: 15745981
[No Abstract] [Full Text] [Related]
5. [A new possible phenotype of carbimazole embryopathy: A case report].
Mellerio H; Gay CL; Forest MG; Orgiazzi J; Nicolino M
Arch Pediatr; 2010 May; 17(5):511-6. PubMed ID: 20395117
[TBL] [Abstract][Full Text] [Related]
6. Birth defects observed with maternal carbimazole treatment: Six cases reported to Nice's Pharmacovigilance Center.
Koenig D; Spreux A; Hiéronimus S; Chichmanian RM; Bastiani F; Fénichel P; Brucker-Davis F
Ann Endocrinol (Paris); 2010 Dec; 71(6):535-42. PubMed ID: 20934171
[TBL] [Abstract][Full Text] [Related]
7. Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil.
Diav-Citrin O; Ornoy A
Teratology; 2002 Jan; 65(1):38-44. PubMed ID: 11835230
[No Abstract] [Full Text] [Related]
8. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hyperthyroidism in pregnancy and birth defects.
Clementi M; Di Gianantonio E; Cassina M; Leoncini E; Botto LD; Mastroiacovo P;
J Clin Endocrinol Metab; 2010 Nov; 95(11):E337-41. PubMed ID: 20668039
[TBL] [Abstract][Full Text] [Related]
10. [Aplasia cutis congenita and antithyroid drugs during pregnancy: Case series and literature review].
Sachs C; Tebacher-Alt M; Mark M; Cribier B; Lipsker D
Ann Dermatol Venereol; 2016; 143(6-7):423-35. PubMed ID: 27033749
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of hyperthyroidism due to Graves' disease: what is the recommended antithyroid drug during pregnancy?].
Caron P
J Gynecol Obstet Biol Reprod (Paris); 2013 May; 42(3):232-7. PubMed ID: 23312275
[TBL] [Abstract][Full Text] [Related]
12. Thyrotoxicosis in pregnancy.
Emerson CH
Curr Ther Endocrinol Metab; 1994; 5():275-7. PubMed ID: 7704731
[No Abstract] [Full Text] [Related]
13. Choanal atresia: the result of maternal thyrotoxicosis or fetal carbimazole?
Barwell J; Fox GF; Round J; Berg J
Am J Med Genet; 2002 Jul; 111(1):55-6; discussion 54. PubMed ID: 12124735
[TBL] [Abstract][Full Text] [Related]
14. Aplasia cutis congenita and other anomalies associated with methimazole exposure during pregnancy.
Rodríguez-García C; González-Hernández S; Hernández-Martín A; Pérez-Robayna N; Sánchez R; Torrelo A
Pediatr Dermatol; 2011; 28(6):743-745. PubMed ID: 21995270
[TBL] [Abstract][Full Text] [Related]
15. Aplasia cutis congenita and antithyroid drugs.
Izhar R; Ghani T
J Pak Med Assoc; 2002 Nov; 52(11):526-8. PubMed ID: 12585373
[No Abstract] [Full Text] [Related]
16. Safety of antithyroid drugs in pregnancy: update and therapy implications.
Francis T; Francis N; Lazarus JH; Okosieme OE
Expert Opin Drug Saf; 2020 May; 19(5):565-576. PubMed ID: 32223355
[No Abstract] [Full Text] [Related]
17. Carbimazole embryopathy.
El Guendouz F; Hammoune N; Hommadi A; Zerhouni H; Baizri H
Ann Endocrinol (Paris); 2017 Oct; 78(5):478-480. PubMed ID: 28870708
[No Abstract] [Full Text] [Related]
18. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
[TBL] [Abstract][Full Text] [Related]
19. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
20. Agranulocytosis associated with anti-thyroid drug in patients with Graves' thyrotoxicosis--report of 11 cases.
Li KL; Huang HS; Wang PW; Lin JD; Juang JH; Liu RT; Huang BY; Huang MJ
Changgeng Yi Xue Za Zhi; 1991 Sep; 14(3):168-73. PubMed ID: 1718579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
